Table of Contents
1 INDUSTRY OUTLOOK 9
1.1 Industry overview 9
1.2 Total addressable market 9
1.3 Industry Trends 10
2 Report Outline 11
2.1 Report Scope 11
2.2 Report Summary 11
2.3 Research Methodology 12
2.4 Report Assumptions 12
3 Market Snapshot 13
3.1 Market Definition - Infoholic Research 13
3.2 Advantage of cancer diagnostics 13
3.3 Disadvantage of cancer diagnostics 13
3.4 Segmented Addressable Market (SAM) 14
3.5 Trends of the cancer diagnostics market 14
3.6 Related Markets 15
3.6.1 Companion diagnostics 15
3.6.2 Genetic testing 16
3.6.3 Point-of-Care Diagnostics 16
4 Market Outlook 16
4.1 Overview 16
4.2 Funding scenario 17
4.3 Market segmentation 19
4.4 PEST Analysis 19
4.5 Porter 5(Five) Forces 20
5 Market Characteristics 22
5.1 DRO - Global Cancer Diagnostics Market Dynamics 22
5.1.1 Drivers 22
5.1.1.1 Rising incidence of cancer globally 22
5.1.1.2 Growing geriatric population 23
5.1.1.3 Growing demand of personalized medicine 23
5.1.2 Opportunities 24
5.1.2.1 Revolutionary nanotechnology in cancer diagnostics 24
5.1.2.2 Increasing medical tourism 24
5.1.3 Restraints 25
5.1.3.1 High cost of diagnosis 25
5.1.3.2 Lack of skilled professionals 25
6 Method of Diagnosis: Market Size and Analysis 28
6.1 Overview 28
6.2 Tumor biomarker tests 29
6.3 Tissue diagnostics 31
6.4 Liquid biopsy 32
6.5 Imaging 33
6.5.1 Magnetic resonance imaging (MRI) 35
6.5.2 Computed tomography (CT) 35
6.5.3 Ultrasound 35
6.5.4 Mammography 36
6.5.5 Nuclear imaging 36
6.6 Others 36
7 Application: Market Size and Analysis 37
7.1 Overview 37
7.2 Lung cancer 38
7.3 Breast cancer 39
7.4 Colorectal cancer 39
7.5 Prostate cancer 40
7.6 Others 40
8 End Users: Market Size and Analysis 41
8.1 Overview 41
8.2 Hospitals 42
8.3 Diagnostic Laboratories 42
8.4 Academic & research institutes 42
8.5 Others 43
9 Regions: Market Size and Analysis 43
9.1 Overview 43
9.2 North America 44
9.2.1 Overview 44
9.2.2 US 45
9.2.3 Canada 46
9.3 Europe 46
9.3.1 Overview 46
9.3.2 UK 47
9.3.3 Germany 47
9.3.4 France 48
9.3.5 Spain 48
9.4 APAC 48
9.4.1 Overview 48
9.4.2 India 49
9.4.3 China 50
9.5 Rest of the World 50
10 Competitive Landscape 52
10.1 Overview 52
11 Vendor Profiles 56
11.1 F.Hoffmann-La Roche Ltd 56
11.1.1 Overview 56
11.1.2 Business Unit 59
11.1.3 Geographic Presence 60
11.1.4 61
11.1.5 Business Focus 61
11.1.6 SWOT Analysis 61
11.1.7 Business Strategy 62
11.2 Abbott Laboratories 63
11.2.1 Overview 63
11.2.2 Business Unit 69
11.2.3 Geographic Presence 69
11.2.4 Business Focus 70
11.2.5 SWOT Analysis 71
11.2.6 Business Strategy 71
11.3 Siemens Healthineers (Siemens AG) 72
11.3.1 Overview 72
11.3.2 Business Units 77
11.3.3 Geographic Presence 79
11.3.4 Business Focus 79
11.3.5 SWOT Analysis 80
11.3.6 Business Strategy 80
11.4 Thermo Fisher Scientific Inc. 81
11.4.1 Overview 81
11.4.2 Geographic Presence 87
11.4.3 Business Focus 87
11.4.4 SWOT Analysis 88
11.4.5 Business Strategies 88
11.5 GE Healthcare 89
11.5.1 Overview 89
11.5.1.1 Business unit 94
11.5.1.2 Business focus 95
11.5.1.3 SWOT analysis 95
11.5.2 Business Strategy 96
12 Companies to Watch For 97
12.1 Qiagen N.V. 97
12.1.1 Overview 97
12.2 BioMerieux S.A. 100
12.2.1 Overview 100
12.2.2 BioMerieux S.A.: Recent Developments 101
12.3 Agilent Technologies' Inc 102
12.3.1 Overview 102
12.3.2 Agilent Technologies: Recent Developments 103
12.4 Becton Dickinson and Company 105
12.4.1 Overview 105
12.4.2 Becton dickenson and company: Recent Developments 105
12.5 Hologic Inc. 106
12.5.1 Overview 106
12.5.2 Hologic Inc.: Recent Developments 106
12.6 Illumina' Inc. 108
12.6.1 Overview 108
12.6.2 Illumina Inc.: Recent Developments 109
12.7 Koninklijke Philips N.V. 112
12.7.1 Overview 112
12.7.2 Koninklijke Philips N.V.: Recent Developments 114
13 Annexure 116
13.1 Abbreviations 116